Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: A systematic review and meta-analysis
Author:
Publisher
Wiley
Subject
Neurology (clinical),Neurology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1528-1167.2011.03047.x/fullpdf
Reference42 articles.
1. Does comparative effectiveness have a comparative edge?;Alexander;JAMA,2009
2. Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines;Beghi;Lancet Neurol,2004
3. Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: systematic review and meta-analysis;Beyenburg;Epilepsia,2010
4. Key factors in the discovery and development of new antiepileptic drugs;Bialer;Nat Rev Drug Discov,2010
5. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center;Bootsma;Epilepsy Behav,2004
Cited by 110 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cenobamate add-on therapy for drug-resistant focal epilepsy;Cochrane Database of Systematic Reviews;2024-08-01
2. Efficacy, tolerability and safety of add-on third-generation antiseizure medications in treating focal seizures worldwide: a network meta-analysis of randomised, placebo-controlled trials;eClinicalMedicine;2024-04
3. Failure to use new breakthrough treatments for epilepsy;Epilepsia;2023-04-11
4. Cost‐effectiveness of cenobamate for focal seizures in people with drug‐resistant epilepsy;Epilepsia;2023-02-14
5. Recent advances in pharmacotherapy for epilepsy;Current Opinion in Neurology;2023-02-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3